Quadrant Capital Group LLC Aura Biosciences, Inc. Transaction History
Quadrant Capital Group LLC
- $3 Billion
- Q3 2025
A detailed history of Quadrant Capital Group LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 87 shares of AURA stock, worth $481. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87Holding current value
$481% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
106Shares Held
52.1MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$38.3 Million66.99% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$28.2 Million1.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$27 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$25.5 Million1.06% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$24.2 Million0.81% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $162M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...